These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 20470256)

  • 1. Predictable and less predictable unwanted cardiac drugs effects: individual pre-disposition and transient precipitating factors.
    Fabritz L; Kirchhof P
    Basic Clin Pharmacol Toxicol; 2010 Mar; 106(3):263-8. PubMed ID: 20470256
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Minimizing the risks associated with QTc prolongation in people with schizophrenia. A consensus statement by the Cardiac Safety in Schizophrenia Group].
    Ames D; Camm J; Cook P; Falkai P; Gury C; Hurley R; Johnson G; Piepho R; Vieweg V;
    Encephale; 2002; 28(6 Pt 1):552-62. PubMed ID: 12506268
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proarrhythmia as a pharmacogenomic entity: a critical review and formulation of a unifying hypothesis.
    Roden DM
    Cardiovasc Res; 2005 Aug; 67(3):419-25. PubMed ID: 15936006
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drug-induced long QT and torsade de pointes: recent advances.
    Kannankeril PJ; Roden DM
    Curr Opin Cardiol; 2007 Jan; 22(1):39-43. PubMed ID: 17143043
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Ventricular arrhythmias. A potential risk associated with the use of non-cardiovascular drugs prolonging the QT interval].
    Calderone V; Cavero I
    Minerva Med; 2002 Jun; 93(3):181-97. PubMed ID: 12094149
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Arrhythmogenic effects of non cardiovascular drugs].
    Davy JM; Raczka F; Beck L; Cung TT; Piot C; Weissenburger J
    Arch Mal Coeur Vaiss; 2003 Dec; 96 Spec No 7():37-45. PubMed ID: 15272520
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Cardiac effects of antipsychotics: mechanism of arrhythmias and sudden cardiac death].
    Kecskeméti V
    Neuropsychopharmacol Hung; 2004 Mar; 6(1):5-12. PubMed ID: 15125308
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drug-induced long QT syndrome and torsade de pointes.
    Morissette P; Hreiche R; Turgeon J
    Can J Cardiol; 2005 Aug; 21(10):857-64. PubMed ID: 16107909
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prolongation of the QT interval and cardiac arrhythmias associated with cisapride: limitations of the pharmacoepidemiological studies conducted and proposals for the future.
    Layton D; Key C; Shakir SA
    Pharmacoepidemiol Drug Saf; 2003; 12(1):31-40. PubMed ID: 12616845
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Ventricular pro-arrhythmic effects of anti-arrhythmia drugs].
    Jaillon P; Simon T
    Therapie; 1992; 47(3):187-92. PubMed ID: 1295119
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Side effects, unwanted drug interactions and the problem of cardiotoxicity].
    Woroń J; Trabka-Janik E; Kostka-Trabka E
    Przegl Lek; 2003; 60(4):196-8. PubMed ID: 14569882
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long QT syndrome caused by noncardiac drugs.
    Viskin S; Justo D; Halkin A; Zeltser D
    Prog Cardiovasc Dis; 2003; 45(5):415-27. PubMed ID: 12704598
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Antipsychotic drugs and cardiovascular safety: current studies of prolonged QT interval and risk of ventricular arrhythmia].
    Gury C; Canceil O; Iaria P
    Encephale; 2000; 26(6):62-72. PubMed ID: 11217540
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drug-induced QT prolongation and proarrhythmia: an inevitable link?
    Ahmad K; Dorian P
    Europace; 2007 Sep; 9 Suppl 4():iv16-22. PubMed ID: 17766320
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiovascular effects of antipsychotics used in bipolar illness.
    Piepho RW
    J Clin Psychiatry; 2002; 63 Suppl 4():20-3. PubMed ID: 11913671
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drugs, QT interval abnormalities and ventricular arrhythmias.
    Thomas SH
    Adverse Drug React Toxicol Rev; 1994; 13(2):77-102. PubMed ID: 7918900
    [No Abstract]   [Full Text] [Related]  

  • 17. Drug-induced QT interval prolongation--regulatory guidance and perspectives on hERG channel studies.
    Shah RR
    Novartis Found Symp; 2005; 266():251-80; discussion 280-5. PubMed ID: 16050273
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Schizophrenia, antipsychotic drugs, and cardiovascular disease.
    Glassman AH
    J Clin Psychiatry; 2005; 66 Suppl 6():5-10. PubMed ID: 16107178
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antidepressants: their effects on cardiac channels, QT prolongation and Torsade de Pointes.
    Sala M; Coppa F; Cappucciati C; Brambilla P; d'Allio G; Caverzasi E; Barale F; De Ferrari GM
    Curr Opin Investig Drugs; 2006 Mar; 7(3):256-63. PubMed ID: 16555686
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Why is QT interval interesting?].
    Elming H; Sonne J; Lublin HK
    Ugeskr Laeger; 2002 Feb; 164(6):750-4. PubMed ID: 11851179
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.